BELL:LSE Belluscura Plc

GBX 8.00 0.25 3.225806
Icon

Belluscura Plc (BELL:LSE) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 8.00

+0.25 (+3.23)%

GBX 0.01B

0.26M

N/A

N/A

Icon

BELL:LSE

Belluscura Plc (GBX)
COMMON STOCK | LSE
GBX 8.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.01B

N/A

GBX 8.00

Belluscura Plc (BELL:LSE) Stock Forecast

N/A

Based on the Belluscura Plc stock forecast from 0 analysts, the average analyst target price for Belluscura Plc is not available over the next 12 months. Belluscura Plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Belluscura Plc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Belluscura Plc’s stock price was GBX 8.00. Belluscura Plc’s stock price has changed by -11.11% over the past week, -60.00% over the past month and -80.25% over the last year.

No recent analyst target price found for Belluscura Plc
No recent average analyst rating found for Belluscura Plc

Company Overview Belluscura Plc

Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLOR, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

https://www.belluscura.com

15 Fetter Lane, London, United Kingdom, EC4A 1BW

24

December

GBX

UK

Adjusted Closing Price for Belluscura Plc (BELL:LSE)

Loading...

Unadjusted Closing Price for Belluscura Plc (BELL:LSE)

Loading...

Share Trading Volume for Belluscura Plc Shares

Loading...

Compare Performance of Belluscura Plc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BELL:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Belluscura Plc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SN:LSE
Smith & Nephew PLC -5.00 (-0.52%) GBX9.12B 41.32 11.38

ETFs Containing BELL

Symbol Name BELL's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Belluscura Plc (BELL:LSE) Stock

Stock Target Advisor's fundamental analysis for Belluscura Plc's stock is Bearish.

Unfortunately we do not have enough data on BELL:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BELL:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BELL:LSE's stock to indicate if its overvalued.

The last closing price of BELL:LSE's stock was GBX 8.00.

The most recent market capitalization for BELL:LSE is GBX 0.01B.

Unfortunately we do not have enough analyst data on BELL:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Belluscura Plc's stock.

As per our most recent records Belluscura Plc has 24 Employees.

Belluscura Plc's registered address is 15 Fetter Lane, London, United Kingdom, EC4A 1BW. You can get more information about it from Belluscura Plc's website at https://www.belluscura.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...